These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27631624)
21. Preparation of a naïve library of camelid single domain antibodies. Olichon A; de Marco A Methods Mol Biol; 2012; 911():65-78. PubMed ID: 22886246 [TBL] [Abstract][Full Text] [Related]
22. The development of activating and inhibiting camelid VHH domains against human protein kinase C epsilon. Paalanen MM; Ekokoski E; El Khattabi M; Tuominen RK; Verrips CT; Boonstra J; Blanchetot C Eur J Pharm Sci; 2011 Mar; 42(4):332-9. PubMed ID: 21220006 [TBL] [Abstract][Full Text] [Related]
23. Homology modeling of a Camelid antibody fragment against a conserved region of Acinetobacter baumannii biofilm associated protein (Bap). Sefid F; Rasooli I; Payandeh Z J Theor Biol; 2016 May; 397():43-51. PubMed ID: 26907201 [TBL] [Abstract][Full Text] [Related]
24. Isolation of TGF-β-neutralizing single-domain antibodies of predetermined epitope specificity using next-generation DNA sequencing. Henry KA; Hussack G; Collins C; Zwaagstra JC; Tanha J; MacKenzie CR Protein Eng Des Sel; 2016 Oct; 29(10):439-443. PubMed ID: 27613412 [TBL] [Abstract][Full Text] [Related]
25. Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors. Calpe S; Correia AC; Sancho-Serra Mdel C; Krishnadath KK MAbs; 2016; 8(4):678-88. PubMed ID: 26967714 [TBL] [Abstract][Full Text] [Related]
26. Improving the tolerance of a protein a analogue to repeated alkaline exposures using a bypass mutagenesis approach. Linhult M; Gülich S; Gräslund T; Simon A; Karlsson M; Sjöberg A; Nord K; Hober S Proteins; 2004 May; 55(2):407-16. PubMed ID: 15048831 [TBL] [Abstract][Full Text] [Related]
27. Camelid nanobodies: killing two birds with one stone. Desmyter A; Spinelli S; Roussel A; Cambillau C Curr Opin Struct Biol; 2015 Jun; 32():1-8. PubMed ID: 25614146 [TBL] [Abstract][Full Text] [Related]
28. Development and production of nanobodies specifically against green fluorescence protein. Fang Z; Cao D; Qiu J Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250 [TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of novel IgG affinity resin coupling anti-Fc camelid single-domain antibodies. Tu Z; Xu Y; Fu J; Huang Z; Wang Y; Liu B; Tao Y J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():26-31. PubMed ID: 25614967 [TBL] [Abstract][Full Text] [Related]
30. Mirror-Image Single-Domain Antibody for a Novel Nonimmunogenic Drug Scaffold. Aoki K; Manabe A; Kimura H; Katoh Y; Inuki S; Ohno H; Nonaka M; Oishi S Bioconjug Chem; 2023 Nov; 34(11):2055-2065. PubMed ID: 37883660 [TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies. Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255 [TBL] [Abstract][Full Text] [Related]
34. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten. Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035 [TBL] [Abstract][Full Text] [Related]
35. VHH characterization.Recombinant VHHs: Production, characterization and affinity. Chabrol E; Stojko J; Nicolas A; Botzanowski T; Fould B; Antoine M; Cianférani S; Ferry G; Boutin JA Anal Biochem; 2020 Jan; 589():113491. PubMed ID: 31676284 [TBL] [Abstract][Full Text] [Related]
36. Anti-idiotypic protein domains selected from protein A-based affibody libraries. Eklund M; Axelsson L; Uhlén M; Nygren PA Proteins; 2002 Aug; 48(3):454-62. PubMed ID: 12112671 [TBL] [Abstract][Full Text] [Related]
37. Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms. Brilhante-da-Silva N; de Oliveira Sousa RM; Arruda A; Dos Santos EL; Marinho ACM; Stabeli RG; Fernandes CFC; Pereira SDS Mol Diagn Ther; 2021 Jul; 25(4):439-456. PubMed ID: 34146333 [TBL] [Abstract][Full Text] [Related]
38. Isolation of Camelid Single-Domain Antibodies Against Native Proteins Using Recombinant Multivalent Peptide Ligands. Alturki NA; Henry KA; MacKenzie CR; Arbabi-Ghahroudi M Methods Mol Biol; 2015; 1348():167-89. PubMed ID: 26424272 [TBL] [Abstract][Full Text] [Related]
39. Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains. Alvarez-Cienfuegos A; Nuñez-Prado N; Compte M; Cuesta AM; Blanco-Toribio A; Harwood SL; Villate M; Merino N; Bonet J; Navarro R; Muñoz-Briones C; Sørensen KM; Mølgaard K; Oliva B; Sanz L; Blanco FJ; Alvarez-Vallina L Sci Rep; 2016 Jun; 6():28643. PubMed ID: 27345490 [TBL] [Abstract][Full Text] [Related]
40. Generation of camelid VHH bispecific constructs via in-cell intein-mediated protein trans-splicing. Shibuya Y; Haga N; Asano R; Nakazawa H; Hattori T; Takeda D; Sugiyama A; Kurotani R; Kumagai I; Umetsu M; Makabe K Protein Eng Des Sel; 2017 Jan; 30(1):15-21. PubMed ID: 27881685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]